Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis

Kaleb D Michaud, Montserrat Vera-Llonch, Gerry Oster

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Objective. Patients with rheumatoid arthritis (RA) are at increased risk of death. Modern RA therapy has been shown to improve health status, but the relationship of such improvements to mortality risk is unknown. We assessed the relationship between health status and all-cause mortality in patients with RA, using the Health Assessment Questionnaire (HAQ) and the Medical Outcomes Study Short Form-36 questionnaire (SF-36) physical and mental component summary scores (PCS, MCS). Methods. Subjects (n = 10,319) were selected from the National Data Bank for Rheumatic Diseases, a prospective longitudinal observational US study with semiannual assessments of HAQ, PCS, and MCS. Risk of death up to 7 years through 2006 was obtained from the US National Death Index. Relationship of HAQ, PCS, and MCS to mortality was assessed using Cox regression models; prediction accuracy was compared using Harrell's concordance coefficient (C). Results. Over 64,888 patient-years of followup, there were 1317 deaths. Poorer baseline health status was associated with greater mortality risk. Adjusting for age, sex, and baseline PCS and MCS, declines in PCS and HAQ were associated with higher risk of death. HAQ improvement was associated with reduced mortality risk from 6 months through 3 years; a similar relationship was not observed for PCS or MCS improvement. Controlling for baseline values, change in PCS or HAQ did not improve prediction accuracy. Conclusion. The HAQ and the SF-36 PCS are similarly and strongly associated with mortality risk in patients with RA. Change in these measures over time does not appear to add to predictive accuracy over baseline levels. The Journal of Rheumatology

Original languageEnglish (US)
Pages (from-to)54-59
Number of pages6
JournalJournal of Rheumatology
Volume39
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Rheumatoid Arthritis
Quality of Life
Mortality
Health
Health Status
Surveys and Questionnaires
Rheumatology
Rheumatic Diseases
Proportional Hazards Models
Observational Studies
Outcome Assessment (Health Care)
Databases

Keywords

  • Health assessment questionnaire
  • Health status
  • Mortality
  • Rheumatoid arthritis
  • SF-36

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis. / Michaud, Kaleb D; Vera-Llonch, Montserrat; Oster, Gerry.

In: Journal of Rheumatology, Vol. 39, No. 1, 01.01.2012, p. 54-59.

Research output: Contribution to journalArticle

@article{fe8ae6e7695a4f7a85551e09707ae5aa,
title = "Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis",
abstract = "Objective. Patients with rheumatoid arthritis (RA) are at increased risk of death. Modern RA therapy has been shown to improve health status, but the relationship of such improvements to mortality risk is unknown. We assessed the relationship between health status and all-cause mortality in patients with RA, using the Health Assessment Questionnaire (HAQ) and the Medical Outcomes Study Short Form-36 questionnaire (SF-36) physical and mental component summary scores (PCS, MCS). Methods. Subjects (n = 10,319) were selected from the National Data Bank for Rheumatic Diseases, a prospective longitudinal observational US study with semiannual assessments of HAQ, PCS, and MCS. Risk of death up to 7 years through 2006 was obtained from the US National Death Index. Relationship of HAQ, PCS, and MCS to mortality was assessed using Cox regression models; prediction accuracy was compared using Harrell's concordance coefficient (C). Results. Over 64,888 patient-years of followup, there were 1317 deaths. Poorer baseline health status was associated with greater mortality risk. Adjusting for age, sex, and baseline PCS and MCS, declines in PCS and HAQ were associated with higher risk of death. HAQ improvement was associated with reduced mortality risk from 6 months through 3 years; a similar relationship was not observed for PCS or MCS improvement. Controlling for baseline values, change in PCS or HAQ did not improve prediction accuracy. Conclusion. The HAQ and the SF-36 PCS are similarly and strongly associated with mortality risk in patients with RA. Change in these measures over time does not appear to add to predictive accuracy over baseline levels. The Journal of Rheumatology",
keywords = "Health assessment questionnaire, Health status, Mortality, Rheumatoid arthritis, SF-36",
author = "Michaud, {Kaleb D} and Montserrat Vera-Llonch and Gerry Oster",
year = "2012",
month = "1",
day = "1",
doi = "10.3899/jrheum.110491",
language = "English (US)",
volume = "39",
pages = "54--59",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "1",

}

TY - JOUR

T1 - Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis

AU - Michaud, Kaleb D

AU - Vera-Llonch, Montserrat

AU - Oster, Gerry

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Objective. Patients with rheumatoid arthritis (RA) are at increased risk of death. Modern RA therapy has been shown to improve health status, but the relationship of such improvements to mortality risk is unknown. We assessed the relationship between health status and all-cause mortality in patients with RA, using the Health Assessment Questionnaire (HAQ) and the Medical Outcomes Study Short Form-36 questionnaire (SF-36) physical and mental component summary scores (PCS, MCS). Methods. Subjects (n = 10,319) were selected from the National Data Bank for Rheumatic Diseases, a prospective longitudinal observational US study with semiannual assessments of HAQ, PCS, and MCS. Risk of death up to 7 years through 2006 was obtained from the US National Death Index. Relationship of HAQ, PCS, and MCS to mortality was assessed using Cox regression models; prediction accuracy was compared using Harrell's concordance coefficient (C). Results. Over 64,888 patient-years of followup, there were 1317 deaths. Poorer baseline health status was associated with greater mortality risk. Adjusting for age, sex, and baseline PCS and MCS, declines in PCS and HAQ were associated with higher risk of death. HAQ improvement was associated with reduced mortality risk from 6 months through 3 years; a similar relationship was not observed for PCS or MCS improvement. Controlling for baseline values, change in PCS or HAQ did not improve prediction accuracy. Conclusion. The HAQ and the SF-36 PCS are similarly and strongly associated with mortality risk in patients with RA. Change in these measures over time does not appear to add to predictive accuracy over baseline levels. The Journal of Rheumatology

AB - Objective. Patients with rheumatoid arthritis (RA) are at increased risk of death. Modern RA therapy has been shown to improve health status, but the relationship of such improvements to mortality risk is unknown. We assessed the relationship between health status and all-cause mortality in patients with RA, using the Health Assessment Questionnaire (HAQ) and the Medical Outcomes Study Short Form-36 questionnaire (SF-36) physical and mental component summary scores (PCS, MCS). Methods. Subjects (n = 10,319) were selected from the National Data Bank for Rheumatic Diseases, a prospective longitudinal observational US study with semiannual assessments of HAQ, PCS, and MCS. Risk of death up to 7 years through 2006 was obtained from the US National Death Index. Relationship of HAQ, PCS, and MCS to mortality was assessed using Cox regression models; prediction accuracy was compared using Harrell's concordance coefficient (C). Results. Over 64,888 patient-years of followup, there were 1317 deaths. Poorer baseline health status was associated with greater mortality risk. Adjusting for age, sex, and baseline PCS and MCS, declines in PCS and HAQ were associated with higher risk of death. HAQ improvement was associated with reduced mortality risk from 6 months through 3 years; a similar relationship was not observed for PCS or MCS improvement. Controlling for baseline values, change in PCS or HAQ did not improve prediction accuracy. Conclusion. The HAQ and the SF-36 PCS are similarly and strongly associated with mortality risk in patients with RA. Change in these measures over time does not appear to add to predictive accuracy over baseline levels. The Journal of Rheumatology

KW - Health assessment questionnaire

KW - Health status

KW - Mortality

KW - Rheumatoid arthritis

KW - SF-36

UR - http://www.scopus.com/inward/record.url?scp=84855387717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855387717&partnerID=8YFLogxK

U2 - 10.3899/jrheum.110491

DO - 10.3899/jrheum.110491

M3 - Article

C2 - 22089466

AN - SCOPUS:84855387717

VL - 39

SP - 54

EP - 59

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 1

ER -